FDA Seeks Real-Time Data On CBD In Reopened Public Hearing Docket

By Beth Wang / March 11, 2020 at 2:46 PM
FDA on Tuesday (March 10) officially reopened its April 2019 cannabidiol comment docket on Regulations.gov in order to gather up-to-date information on CBD as it crafts regulations and determines whether to allow the compound to be used in consumer products, including foods and dietary supplements. The agency indicated last week that it would reopen the docket , which received more than 4,000 comments before it closed last July. The docket will remain open indefinitely. “In light of the continued...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.